Illumina said today it is partnering with the Hartwell Autism Research and Technology Initiative (iHART) to establish a genomic database for autism spectrum disorder (ASD). The effort is part of iHART’s mission to establish the largest shared, open-access repository of bioinformatic data on autism.
In addition to providing insights into ASD, the collaboration aims to develop a user-friendly interface that will be accessible to researchers as well as individuals outside the research community, including families participating in the study.
In addition to providing insights into ASD, the collaboration aims to develop a user-friendly interface that will be accessible to researchers as well as individuals outside the research community, including families participating in the study.
